EFFICACY AND SAFETY OF A SINGLE 400 MG ORAL DOSE OF CEFIXIME IN THE TREATMENT OF UNCOMPLICATED GONORRHEA

被引：12

作者：

KUHLWEIN, A ^{[1
]}

NIES, BA ^{[1
]}

机构：

[1] DEPT MED RES,D-6100 DARMSTADT,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1989年 / 8卷 / 03期

关键词：

D O I：

10.1007/BF01965274

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：261 / 262

页数：2

共 7 条

[1] INVITRO ACTIVITY OF DIFLOXACIN HYDROCHLORIDE (A-56619), A-56620, AND CEFIXIME (CL 284,635-FK 027) AGAINST SELECTED GENITAL PATHOGENS [J].

BOWIE, WR ;

SHAW, CE ;

CHAN, DGW ;

BOYD, J ;

BLACK, WA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :590-593

[2] THE PHARMACOKINETIC AND BACTERICIDAL CHARACTERISTICS OF ORAL CEFIXIME [J].

BRITTAIN, DC ;

SCULLY, BE ;

HIROSE, T ;

NEU, HC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :590-594

[3] INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

AYERS, LW ;

GAVAN, TL ;

GERLACH, EH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162

[4]

GRIMM H, 1987, FORTSCHRITTE ANTIMIK, V6, P1201

[5] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].

NEU, HC ;

CHIN, NX ;

LABTHAVIKUL, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180

[6]

SAITO I, 1985, REV NEW ORAL CEPHEMS, P55

[7]

1987, AM SOC MICROBIOLOGY, V53, P197

← 1 →